Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.074 0.02
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.02
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.071 0.02
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.087 0.02
mRNA barasertib CTRPv2 pan-cancer AAC -0.072 0.02
mRNA GMX-1778 CTRPv2 pan-cancer AAC -0.079 0.02
mRNA YL54 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.072 0.02
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.08 0.02
Download CSV